Merck & Co., Inc: all 2,453 studies
Page 22 of 25. Open to participants first (145), then studies with results posted, then the rest; newest registration first within each.
- Bioequivalence Study of ARQ 197 Amorphous and Crystalline Polymorphs A and B in Normal Healthy VolunteersCompletedNCT00658554Phase 1
- Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With BlepharitisCompletedNCT00656539Phase 4
- Effects of MK7418 on Diuresis and Renal Function in Congestive Heart Failure PatientsCompletedNCT00652782Phase 2
- Journey for Control of Diabetes Study (0431-111)CompletedNCT00652509Not applicable
- A Study of ARQ 197 in Healthy Volunteers to Assess the Pharmacokinetic (PK) Profile in Extensive and Poor Metabolizers as Defined by Cytochrome P450 2C19 (CYP 2C19) GenotypeCompletedNCT00651638Phase 1
- Cubicin(R) for Complicated Post-surgical Wound InfectionsTerminatedNCT00651131Phase 4
- A Study to Test V930/V932 in Patients With Cancers Expressing Human Epidermal Growth Factor Receptor 2 (HER-2) and/or Carcinoembryonic Antigen (CEA)(V930-003)(COMPLETED)CompletedNCT00647114Phase 1
- A Study to Evaluate the Safety, Tolerability and Plasma Concentration Profiles of MK0633 in Asthmatic Children Aged 12 to Less Than 16 Years (0633-019)CompletedNCT00646789Phase 1
- An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Healthy Chinese Adult Subjects (0431-108)(COMPLETED)CompletedNCT00642798Phase 1
- Effect of Vicriviroc on HIV Ribonucleic Acid (RNA) Levels in Cerebrospinal Fluid (Study P05241)CompletedNCT00632073Phase 1
- Safety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With BlepharitisCompletedNCT00629980Phase 4
- Safety and Efficacy Study of AzaSite® in Subjects With BlepharitisCompletedNCT00629941Phase 4
- Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With BlepharitisCompletedNCT00629590Phase 4
- Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung DiseaseCompletedNCT00625612Phase 3
- An Extension Study for Patients Previously Treated With ARQ 501CompletedNCT00622063Phase 1/2
- Antihypertensive Response to Losartan and Genetic PolymorphismsCompletedNCT00617877Not applicable
- A Phase 1 Study of ARQ 197 in Adult Patients With Advanced Solid TumorsCompletedNCT00612703Phase 1
- A Phase 1 Study of ARQ 197 in Adult Patients With Advanced Solid TumorsCompletedNCT00612209Phase 1
- Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634)CompletedNCT00600288Phase 3
- A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate DietCompletedNCT00566267Phase 2/3
- A Study of MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED)CompletedNCT00565292Phase 1
- A Study to Investigate the Influence of MK0859 on Blood Pressure (MK-0859-012)(COMPLETED)CompletedNCT00565006Phase 1
- Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648)CompletedNCT00564421Phase 3
- A Study of MK-8033 in Patients With Advanced Solid Tumors (MK-8033-001)CompletedNCT00559182Phase 1
- A Randomized Phase 2 Study of ARQ 197 Versus Gemcitabine in Treatment-Naïve Patients With Unresectable Locally Advanced or Metastatic Pancreatic AdenocarcinomaCompletedNCT00558207Phase 2
- Phase 2 Study in Patients With MiT TumorsCompletedNCT00557609Phase 2
- A Study of the Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003)CompletedNCT00551915Phase 2
- A Study to Test the Safety and Effectiveness of an Investigational Vaccine in Infants (V419-002)CompletedNCT00551629Phase 2
- Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED)CompletedNCT00551330Phase 2
- A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)CompletedNCT00551187Phase 2
- Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875)CompletedNCT00551018Phase 2
- A Study of Gastric Delay in Migraine Patients (3207-003)CompletedNCT00548353Phase 1
- Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055)CompletedNCT00548080Phase 3
- Dyslipidemia in Type 2 Diabetes (0767-034)TerminatedNCT00547274Phase 3
- GEM 1.5 mg b.i.d. to 4.5 mg b.i.d. Versus Lorazepam in GAD (0777-026)CompletedNCT00546624Phase 2
- A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153)CompletedNCT00546286Phase 3
- Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005)TerminatedNCT00543959Phase 2
- A Study of MK0777 in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-020)CompletedNCT00543920Phase 2
- MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001)CompletedNCT00543868Phase 2
- MK0767 Added to Insulin Therapy in Patients With Type 2 Diabetes (0767-030)TerminatedNCT00543816Phase 3
- Placebo Controlled Metformin and Sulfonylurea Combination Study in Patients With Type 2 Diabetes (0767-025)TerminatedNCT00543751Phase 3
- MK0767 and Metformin Combination Study (0767-028)TerminatedNCT00543738Phase 3
- MK0916 in Patients With Type 2 Diabetes and Metabolic Syndrome (0916-005)CompletedNCT00543595Phase 2
- MK0767 in Type 2 Diabetes (0767-012)TerminatedNCT00543556Phase 2
- Pediatric Expanded Access Program-Oral Solution (0831-908)CompletedNCT00543530Phase 3
- Study A - MK0767 Monotherapy StudyTerminatedNCT00543517Phase 3
- MK0767 and Sulfonylurea Combination Study (0767-027)TerminatedNCT00543491Phase 3
- 12-Week No-Rofecoxib Plus Aspirin Endoscopy Study (0782-003)TerminatedNCT00543465Phase 2
- A Study to Determine the Effectiveness and Tolerability of MK8141 in Patients With High Blood Pressure (MK-8141-006)CompletedNCT00543413Phase 2
- Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)TerminatedNCT00543361Phase 3
- MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)TerminatedNCT00543010Phase 3
- Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis (0812-008)CompletedNCT00542022Phase 2
- A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED)CompletedNCT00541463Phase 2
- Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. PneumoniaeCompletedNCT00540072Phase 3
- A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)TerminatedNCT00539968Phase 1/2
- A Randomized Controlled Study of Rolapitant for the Prevention of Nausea and Vomiting Following Surgery (Study P04937AM1)(COMPLETED)CompletedNCT00539721Phase 2
- Treatment of Patients With Anxiety Disorder (0777-022)CompletedNCT00539578Phase 2
- Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial PneumoniaCompletedNCT00538694Phase 3
- Ridaforolimus in Treatment of Sarcoma-SUCCEED (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Ridaforolimus)(8669-011 AM6)CompletedNCT00538239Phase 3
- A Safety and Tolerability Study of SCH 721015 in Patients With Transitional Cell Carcinoma of the Bladder (Study P03816)CompletedNCT00536588Phase 1
- MK0524A Phase IIb Study (0524A-011)(COMPLETED)CompletedNCT00536237Phase 2
- Endpoint Validation Study (0524A-015)CompletedNCT00533676Phase 2
- Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)CompletedNCT00533650Phase 2
- Effect of MK0524A on Flushing Caused by Niacin (0524A-056)CompletedNCT00533611Phase 3
- A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED)CompletedNCT00533598Phase 2
- Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)CompletedNCT00533481Phase 2
- MK0686 in Postsurgery Dental Pain (0686-002)CompletedNCT00533403Phase 2
- MK0524A Clinical Efficacy Study (0524A-026)(COMPLETED)CompletedNCT00533312Phase 2
- MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)CompletedNCT00533208Phase 2
- An Exploratory Biomarker Study of ARQ 501 in Patients With Advanced Solid TumorsCompletedNCT00524524Phase 1
- Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5)CompletedNCT00523211Phase 3
- Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)CompletedNCT00520598Phase 2
- MK2461 in Patients With Advanced Cancer (2461-001)(COMPLETED)CompletedNCT00518739Phase 1
- Study to Test the Safety of HPV Vaccine in Women (V501-011)(COMPLETED)CompletedNCT00517309Phase 3
- Study of the Efficacy and Safety of SCH 486757 in Subjects With Chronic Cough (Study P04887)CompletedNCT00506987Phase 2
- Study of the Efficacy and Safety of SCH 619734 in Subjects With Chronic Cough From an Unknown Cause (Study P04888)CompletedNCT00506545Phase 2
- A Study of MK0657 in Parkinson's Disease Patients (0657-006)CompletedNCT00505843Phase 1
- A Phase I Dose Escalation Combination Study in Patients With Chronic Myelogenous Leukemia (CML) and Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)(0457-009)(TERMINATED)TerminatedNCT00500006Phase 1
- MK2461 Phase I/II Study in Patients With Advanced Solid Tumors (MK-2461-002 AM1)(COMPLETED)CompletedNCT00496353Phase 1/2
- Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056)CompletedNCT00496327Phase 3
- Safety, Tolerability and Immunogenicity of Pneumovax 23 in Healthy Adults in India (V110-011)CompletedNCT00496093Phase 3
- Safety Study to Evaluate Daptomycin in Non-infected Adults Who Are Either on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis (MK-3009-021)CompletedNCT00490737Phase 1
- A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054)CompletedNCT00489099Phase 3
- A Study of MK0359 in Patients With Chronic Asthma (0359-013)CompletedNCT00482898Phase 2
- Study of Safety, Tolerability and Efficacy of MK0493 in Obese Patients (0493-008)(COMPLETED)CompletedNCT00482638Phase 2
- Efficacy, Pharmacokinetics and Safety of Org 25969 in Subjects With Normal or Impaired Renal Function (19.4.304)(P05948)(COMPLETED)CompletedNCT00482599Phase 3
- MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)CompletedNCT00482430Phase 2
- Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017)CompletedNCT00482417Phase 2
- A Study of MK0359 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0359-016)CompletedNCT00482235Phase 2
- To Study Different Levels of MK0493 for Safety, Efficacy, and Tolerability in Obese Patients (0493-017)(COMPLETED)CompletedNCT00482196Phase 2
- A Study of MK0431 in Patients With Type 2 Diabetes (0431-010)CompletedNCT00482079Phase 2
- A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802)CompletedNCT00481702Phase 3
- A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014)CompletedNCT00481663Phase 2
- Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED)CompletedNCT00474370Phase 3
- Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036)CompletedNCT00451386Phase 2
- Comparison of Rocuronium and Org 25969 With Cisatracurium and Neostigmine (19.4.310)(P05931)CompletedNCT00451100Phase 3
- Safety and Efficacy of Prulifloxacin vs Placebo in Treatment of Acute Gastroenteritis in Adult TravelersCompletedNCT00448422Phase 3
- A De-Escalating Strategy for Antibiotic Treatment of Pneumonia in The Medical Intensive Care Unit (0787B-092)CompletedNCT00445094Phase 4
- ZOSTAVAX(R) Local Registration Trial (V211-019)CompletedNCT00444860Phase 3
- Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or GlaucomaCompletedNCT00443924Phase 1